Axel A. Laminet

732 total citations
12 papers, 625 citations indexed

About

Axel A. Laminet is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Axel A. Laminet has authored 12 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Axel A. Laminet's work include Radiopharmaceutical Chemistry and Applications (4 papers), Bacterial Genetics and Biotechnology (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Axel A. Laminet is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (4 papers), Bacterial Genetics and Biotechnology (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Axel A. Laminet collaborates with scholars based in Germany, United States and Switzerland. Axel A. Laminet's co-authors include Andreas Plückthun, Thomas Ziegelhoffer, Costa Georgopoulos, Gerald Apell, W. Michael Kavanaugh, Leah Conroy, Carol A. Kumamoto, John E. McCartney, Robert M. Hudziak and Hermann Oppermann and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Axel A. Laminet

12 papers receiving 604 citations

Peers

Countries citing papers authored by Axel A. Laminet

Since Specialization

Citations

This map shows the geographic impact of Axel A. Laminet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel A. Laminet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel A. Laminet more than expected).

Fields of papers citing papers by Axel A. Laminet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel A. Laminet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel A. Laminet. The network helps show where Axel A. Laminet may publish in the future.

Co-authorship network of co-authors of Axel A. Laminet

This figure shows the co-authorship network connecting the top 25 collaborators of Axel A. Laminet. A scholar is included among the top collaborators of Axel A. Laminet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel A. Laminet. Axel A. Laminet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Title	Journal	Authors	Indexed citations
1	Affinity, Specificity, and Kinetics of the Interaction of the SHC Phosphotyrosine Binding Domain with Asparagine-X-X-Phosphotyrosine Motifs of Growth Factor Receptors	Journal of Biological Chemistry	Axel A. Laminet, Gerald Apell et al.	59
2	Engineering disulfide-linked single-chain Fv dimers [(sFv')₂] with improved solution and targeting properties: anti-digoxin 26–10 (sFv')₂ and anti-c-erbB-2 741F8 (sFv')₂ made by protein folding and bonded through C-terminal cysteinyl peptides	Protein Engineering Design and Selection	John E. McCartney, Mei-Sheng Tai et al.	42
3	Targeting c-erbB-2 expressing tumors using single-chain Fv monomers and dimers.	PubMed	M S Tai, John E. McCartney et al.	18
4	Mammalian Cell Expression of Single–Chain Fv (sFv) Antibody Proteins and Their C–terminal Fusions with Interleukin–2 and Other Effector Domains	Nature Biotechnology	Haimanti Dorai, John E. McCartney et al.	43
5	Tumor targeting in a murine tumor xenograft model with the (sFv′)2 divalent form of anti-c-erbB-2 single-chain Fv	Cell Biophysics	James S. Huston, Gregory P. Adams et al.	8
6	Thermodynamic Partitioning Model for Hydrophobic Binding of Polypeptides by GroEL	Journal of Molecular Biology	Ralph Zahn, K P Rücknagel et al.	62
7	SINGLE-CHAIN Fv FUSIONS WITH C-TERMINAL CYSTEINE PEPTIDES IsFv′	Journal of Immunotherapy	James S. Huston, John E. McCartney et al.	1
8	Folding in vitro and transport in vivo of pre‐β‐lactamase are SecB independent	Molecular Microbiology	Axel A. Laminet, Carol A. Kumamoto et al.	18
9	Folding in vitro and transport in vivo of pre-beta-lactamase are SecB independent.	PubMed	Axel A. Laminet, Carol A. Kumamoto et al.	19
10	The Escherichia coli heat shock proteins GroEL and GroES modulate the folding of the beta-lactamase precursor.	The EMBO Journal	Axel A. Laminet, Thomas Ziegelhoffer et al.	223
11	The precursor of beta-lactamase: purification, properties and folding kinetics.	The EMBO Journal	Axel A. Laminet, Andreas Plückthun	96
12	Three new restriction endonucleasesMaeI, MaeIIandMaeIIIfromMethanococcus aeolicus	Nucleic Acids Research	Kurt Werner Schmid, Michael Thomm et al.	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact